|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||3.60 / 5.44|
Sanofi and Boehringer Ingelheim confirmed today that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi's animal health business (Merial) and Boehringer Ingelheim's consumer...
New Grants Bring Santander's Total Community-Based Donations in 2016 to Nearly $10 Million
The key trends for 2016 were falling insulin prices, falling returns on R&D and lower approval rates, according to analysts at the French bank.
Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the initiation of the ICARIA-MM Phase III trial of isatuximab, an investigational anti-CD38 monoclonal antibody being studied for the...
Royal Bank of Scotland's stress-test failure marks another twist in a long and winding road to recovery for the beleaguered lender.
RBS misses both key targets in Bank of England tests, says it must "do more" to restore resilience.
A less stringent ECB capital target has investors betting on a bigger payout for shareholders.
Data also Shows Men Consider Sexual Health to be an Important Priority
Here's a technical look at how to trade some of the biggest stocks on Wall Street, including Texas Instruments, Schlumberger and Exxon Mobil.
The postal services operator will merge its fund management unit with bid partner Anima to bulk up for the offer.
The prospect of a trade spat with China puts HSBC in the spotlight as Deutsche Bank wilts on regulation worries.
Significant exposures to Mexico, as well as European economies, leave both bank stocks reeling.
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that the first patient has been enrolled and received an infusion in a pivotal Phase 3 clinical trial named COMET for the...
Bank Launches Self-Service Mobile App Exclusively for Business Customers; Adds New Functionality to its Consumer App to Improve the Customer Experience
Shares in the lender rise more than 4% in early trading.
U.K. lender Lloyds falls after a third-quarter profit miss, while luxury goods maker Kering surges.
Shareholders will also strain for information on the post-Brexit outlook at the Edinburgh lender.
Forward-looking purchasing managers' indices and earnings from beleaguered lender Deutsche Bank feature among the other release highlights.
The sale of a bad loan portfolio to Poland's Kruk follows projections of a pick-up in transactions in the second half of the year.
To Celebrate its Expanding Presence in Philadelphia, Santander Donates a Total of $12,000 to Three Community-Based Non-Profit Organizations